A5049903653- Pharmaceutical Practices and Patient Outcomes
- Schizophrenia research and treatment
- Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Child and Adolescent Psychosocial and Emotional Development
- Mental Health Treatment and Access
- Mental Health and Psychiatry
- Opioid Use Disorder Treatment
- Liver Disease Diagnosis and Treatment
- Substance Abuse Treatment and Outcomes
- Alcohol Consumption and Health Effects
- Hepatitis C virus research
- Primary Care and Health Outcomes
- Streptococcal Infections and Treatments
- Hepatitis B Virus Studies
- Innovations in Medical Education
- Bipolar Disorder and Treatment
- Mental Health Research Topics
- Plant Pathogenic Bacteria Studies
- Digital Mental Health Interventions
- Health Sciences Research and Education
- Prenatal Substance Exposure Effects
- Healthcare Systems and Technology
- Attention Deficit Hyperactivity Disorder
- Treatment of Major Depression
VA Midwest Health Care Network
2024
Indiana University Health
2022
Veterans Health Administration
2020
National Park Service
2020
Richard L. Roudebush VA Medical Center
2017-2019
Indiana University – Purdue University Indianapolis
2019
Eskenazi Health Foundation
2016
Eskenazi Health
2016
Despite the theory that long-acting injectable (LAI) antipsychotics should be more likely to improve adherence, reduce gaps in therapy, and prevent relapse compared with oral antipsychotics, there is little published evidence on this issue, specifically patients early psychosis.Patients a new diagnosis for psychotic disorder between July 1, 2013, August 31, 2014, were retrospectively evaluated during 12-month duration. The primary outcomes adherence persistence. Adherence was determined by...
Abstract Generalized anxiety disorder (GAD) is characterized by persistent and excessive worry. Around half of the patients treated for GAD will fail to respond initial treatment. Treatment-resistant (or refractory) defined as failure at least 1 trial antidepressant therapy adequate dose duration. Review literature indicates several potential medication classes individual agents that can be used augmentation strategies treat residual symptoms when recommended per clinical practice guidelines...
In veterans, the prevalence of 12-month and lifetime alcohol use disorder (AUD) is 14.8% 42.2%, respectively. Alcohol treatment often plagued by medication discontinuation with relapse rates being as high 39% in patients who sought treatment. One proposed benefit long-acting injectable (LAI) medications improved adherence. The purpose this trial was to compare difference time between on oral LAI naltrexone.This study a retrospective electronic chart review AUD were treated or naltrexone at...
Abstract Purpose The complexity of patients with mental healthcare needs cared for by clinical pharmacists is not well delineated. We evaluated the schizophrenia, bipolar disorder, and major depressive disorder (MDD) in Veterans Affairs (VA) health pharmacist practitioners (MH CPPs). Methods Patients at 42 VA sites or MDD 2016 through 2019 were classified MH CPP visits into those 2 more (“ongoing care”), 1 visit (“consultative no (“no care”). Patient each condition was defined medication...
The process of developing a workshop to enhance pharmacy residents' precepting skills and confidence in serving as preceptors is described, survey results indicating the program's effectiveness are presented.In response requests from residents for structured precepting-specific training augment their participation teaching certificate programs, Indianapolis, Indiana-based Eskenazi Health launched series annual workshops designed hone skills. First offered half-day program January 2011, was...
The American Association of Psychiatric Pharmacists (AAPP) used multiple modalities to develop and refine 28 attribute statements describe a best practice model for outpatient psychiatric pharmacists. Before addressing implementation, assessment, field testing, it was necessary finalize confirm the their supporting narratives among stakeholders. objective this project justifications pharmacists providing direct patient care.
Opioid use disorder (OUD) can cause significant morbidity and mortality with more than 115 people dying from an opioid overdose daily in the United States. Treatment buprenorphine/naloxone (BUP/NAL) be effective; however, there is conflicting evidence on utility of higher doses preventing relapse. This study was designed to assess BUP/NAL maintenance rate relapse veterans OUD.Patients diagnosed OUD who received a prescription for through substance recovery program were retrospectively...
A 2019 survey identified significant variability of practice characteristics among outpatient psychiatric pharmacists (OPPs). No published model establishes which attributes constitute best for OPPs. By developing a consensus attributes, OPPs can work toward consistent, effective patient care. This project aimed to develop attribute statements providing direct care.Board Certified Psychiatric Pharmacists and American Association (AAPP) members were questioned using 5-phase (P1-P5) summit...
Hepatitis C virus (HCV) incidence rates are rising for patients with substance use and/or SUDs. Guidelines provide monitoring recommendations to ensure remission after successful treatment. The study's objective was identify gaps in follow-up documented SUD through assessment of adherence guideline-recommended HCV RNA lab 12 months post-treatment.Patients treated the Veteran Health Indiana Pharmacy Clinic were retrospectively evaluated. Subjects categorized based on provider assigned care...